Australian Regulator Rejects Zeltia Group’s Cancer Drug Yondelis

MADRID, Nov 12 (Reuters) - Spanish drug company Zeltia's (ZEL.MC) application to register its key Yondelis anti-cancer drug in Australia has been rejected, the country's Advisory Committee on Prescription Medicines (APCM) said in a report.